The PEVs function as protective compartments that encapsulate and maintain a complex bioactive machinery of proteases and phosphatases (including LMW-PTP), which, upon release, actively modify the tumor microenvironment by degrading the extracellular matrix (e.g., fibronectin). The gene discussed is FN1; the disease is neoplasm.